Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from DocMorris ( (CH:DOCM) ) is now available.
DocMorris Finance B.V., a subsidiary of DocMorris AG, has agreed to repurchase a portion of its 2026 convertible bonds with a nominal value of around CHF 14.4 million, with settlement expected in the coming days. Following the buyback and immediate redemption of these instruments, the outstanding nominal amount of the 2026 convertible bond will fall to below CHF 8.0 million, a sharp reduction from the original CHF 95.0 million issue size, effectively cleaning up the remaining portion of this financing line and further strengthening the group’s capital structure and financial flexibility ahead of key reporting dates in 2026.
The most recent analyst rating on (CH:DOCM) stock is a Hold with a CHF7.00 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.
More about DocMorris
DocMorris AG is a Swiss-listed digital health company active in online pharmacy, telemedicine and health-product marketplaces, with strong brands in Germany and other European countries. It serves around 11 million active customers mainly from a highly automated logistics center in Heerlen, Netherlands, and operates TeleClinic, Germany’s largest telemedicine platform, alongside leading health and care marketplaces in Southern Europe. In 2025, roughly 1,600 employees across Germany, the Netherlands, Spain, France, Portugal and Switzerland generated external sales of CHF 1,186 million, supporting the group’s ambition to be a leading digital health companion in Europe.
Average Trading Volume: 334,626
Technical Sentiment Signal: Sell
Current Market Cap: CHF279M
For detailed information about DOCM stock, go to TipRanks’ Stock Analysis page.